Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

16.50
-0.1100-0.66%
Pre-market: 16.500.00000.00%04:00 EDT
Volume:6.51M
Turnover:107.57M
Market Cap:18.96B
PE:-46.57
High:16.84
Open:16.72
Low:16.40
Close:16.61
52wk High:18.39
52wk Low:9.43
Shares:1.15B
Float Shares:1.14B
Volume Ratio:1.00
T/O Rate:0.57%
Dividend:0.48
Dividend Rate:2.91%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.33
PE(LYR):-5.50

Loading ...

Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback

Simply Wall St.
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY), Viatris (VTRS) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

TIPRANKS
·
Aug 07

Viatris Inc. Stock Sheds 7.7%, Underperforms Market

Dow Jones
·
Aug 07

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook

Benzinga Earnings
·
Aug 07

Movement Alert|Viatris Inc. Falls 5.01% in Regular Trading, Q2 Earnings Beat Triggers Profit-Taking

Market Focus
·
Aug 07

Stock Track | Viatris Plummets 5.04% Intraday as FY Revenue Guidance Midpoint Trails Consensus Despite Q2 Beat

Stock Track
·
Aug 07

U.S. Stocks on the MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International

Reuters
·
Aug 07

Viatris Shares up 2.7% After Q2 Profit Beat

THOMSON REUTERS
·
Aug 06

Viatris Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Viatris Shares Rise 2% Premarket After Co Lifts FY Profit Forecast

THOMSON REUTERS
·
Aug 06

Viatris Raises Annual Profit Forecast on Branded Drug Strength

Reuters
·
Aug 06

Viatris Climbs After Raising Lower End of Annual Revenue Forecast

Reuters
·
Aug 06

Viatris' Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance

MT Newswires Live
·
Aug 06

GUIDANCE: (VTRS) Viatris Expects 2026 Adjusted EPS Range $2.45 - $2.59, vs. FactSet Est of $2.45

MT Newswires Live
·
Aug 06

Harrow to Buy Dry Eye Nasal Spray Tyrvaya from Viatris for up to $100 Million

Reuters
·
Aug 06

Opus Genetics Q2 FY26 Net Loss Widens to $8.1 Million; Revenue Drops to $755,000

Reuters
·
Aug 06

Viatris Q2 FY26 Net Loss Widens to $119 Million; Revenue Rises 5% to $3.8 Billion

Reuters
·
Aug 06

Viatris Q2 Adj. EPS $0.69 Beats $0.60 Estimate, Sales $3.756B Beat $3.675B Estimate

Benzinga Earnings
·
Aug 06

Viatris Q2 Adjusted EPS USD 0.69 Vs. IBES Estimate USD 0.6

Reuters
·
Aug 06